Shigeto Kawai

1.0k total citations
28 papers, 837 citations indexed

About

Shigeto Kawai is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shigeto Kawai has authored 28 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Immunology. Recurrent topics in Shigeto Kawai's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Shigeto Kawai is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Shigeto Kawai collaborates with scholars based in Japan, United States and United Kingdom. Shigeto Kawai's co-authors include Shuji Ozaki, Masamichi Sugimoto, Akito Nakamura, Makoto Okazaki, Masahiko Mihara, Yoshihiro Matsumoto, Yoshiyuki Ohsugi, Masaaki Kosaka, Yasuo Koishihara and Toshihiko Ohtomo and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Shigeto Kawai

27 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeto Kawai Japan 14 339 281 188 152 145 28 837
Arnaud Dupuy d’Angeac France 11 251 0.7× 410 1.5× 169 0.9× 52 0.3× 105 0.7× 28 886
Barbara J. Vilen United States 18 271 0.8× 860 3.1× 115 0.6× 68 0.4× 152 1.0× 31 1.2k
Keisuke Horikawa Australia 16 320 0.9× 908 3.2× 188 1.0× 68 0.4× 165 1.1× 28 1.3k
Gabriele Beck‐Engeser United States 19 465 1.4× 563 2.0× 151 0.8× 42 0.3× 210 1.4× 31 1.0k
Erica N Evans United States 19 487 1.4× 379 1.3× 187 1.0× 232 1.5× 80 0.6× 44 1.2k
A. Miyajima Japan 14 348 1.0× 452 1.6× 223 1.2× 61 0.4× 100 0.7× 27 992
Boris Brill Germany 15 266 0.8× 177 0.6× 183 1.0× 108 0.7× 50 0.3× 33 578
Meina Tang United States 14 574 1.7× 521 1.9× 198 1.1× 77 0.5× 609 4.2× 26 1.2k
R. E. Schmidt Germany 18 388 1.1× 803 2.9× 231 1.2× 119 0.8× 189 1.3× 40 1.4k
John Marken United States 9 607 1.8× 280 1.0× 294 1.6× 587 3.9× 78 0.5× 13 1.5k

Countries citing papers authored by Shigeto Kawai

Since Specialization
Citations

This map shows the geographic impact of Shigeto Kawai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeto Kawai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeto Kawai more than expected).

Fields of papers citing papers by Shigeto Kawai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeto Kawai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeto Kawai. The network helps show where Shigeto Kawai may publish in the future.

Co-authorship network of co-authors of Shigeto Kawai

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeto Kawai. A scholar is included among the top collaborators of Shigeto Kawai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeto Kawai. Shigeto Kawai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mochizuki, Tatsuki, Shigeto Kawai, Tatsuhiko Tachibana, et al.. (2025). Robust and reproducible human intestinal organoid-derived monolayer model for analyzing drug absorption. Scientific Reports. 15(1). 11403–11403. 1 indexed citations
2.
Kawai, Shigeto, et al.. (2023). Development of rat duodenal monolayer model with effective barrier function from rat organoids for ADME assay. Scientific Reports. 13(1). 12130–12130. 3 indexed citations
3.
Kawai, Shigeto, Kiyotaka Nakano, Keiichi Tamai, et al.. (2021). Generation of a lung squamous cell carcinoma three-dimensional culture model with keratinizing structures. Scientific Reports. 11(1). 24305–24305. 3 indexed citations
4.
Kawai, Shigeto, Masaki Yamazaki, Keita Shibuya, et al.. (2020). Three-dimensional culture models mimic colon cancer heterogeneity induced by different microenvironments. Scientific Reports. 10(1). 3156–3156. 22 indexed citations
5.
Yamazaki, Masaki, Atsuhiko Kato, Eiji Oki, et al.. (2020). Continuous formation of small clusters with LGR5-positive cells contributes to tumor growth in a colorectal cancer xenograft model. Laboratory Investigation. 101(1). 12–25. 2 indexed citations
6.
Funahashi, S., Shigeto Kawai, Etsuko Fujii, et al.. (2018). Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma. The Journal of Biochemistry. 164(6). 471–481. 4 indexed citations
7.
Fujii, Etsuko, Masaki Yamazaki, Shigeto Kawai, et al.. (2017). A simple method for histopathological evaluation of organoids. Journal of Toxicologic Pathology. 31(1). 81–85. 25 indexed citations
8.
Kuwahara, Motoi, Hidekazu Suzuki, Naomi Oka, et al.. (2017). Therapeutic strategy and electron microscopic abnormality in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 igG4 antibody. Journal of the Neurological Sciences. 381. 649–650. 3 indexed citations
9.
Funahashi, S., et al.. (2016). Generation and characterization of monoclonal antibodies against human LGR6. The Journal of Biochemistry. 161(4). 361–368. 1 indexed citations
10.
Harada, Takeshi, Shuji Ozaki, Asuka Oda, et al.. (2013). Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors. PLoS ONE. 8(12). e83905–e83905. 13 indexed citations
11.
12.
Ishiguro, Takahiro, Shigeto Kawai, Kiyoshi Habu, et al.. (2010). A defucosylated anti‐CD317 antibody exhibited enhanced antibody‐dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients. Cancer Science. 101(10). 2227–2233. 18 indexed citations
13.
Kawai, Shigeto, Yumiko Azuma, Etsuko Fujii, et al.. (2008). Interferon‐α enhances CD317 expression and the antitumor activity of anti‐CD317 monoclonal antibody in renal cell carcinoma xenograft models. Cancer Science. 99(12). 2461–2466. 39 indexed citations
14.
Kawai, Shigeto, Yasuo Koishihara, Shinichiro Iida, et al.. (2006). Construction of a conventional non-radioisotope method to quantify HM1.24 antigens: Correlation of HM1.24 levels and ADCC activity of the humanized antibody against HM1.24. Leukemia Research. 30(8). 949–956. 12 indexed citations
15.
Mihara, Masahiko, Makoto Okazaki, Akito Nakamura, et al.. (2005). Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. International Immunopharmacology. 5(12). 1731–1740. 258 indexed citations
16.
Peggs, Karl S., I Sanjuán, Arnold Pizzey, et al.. (2005). Generation of Potent Antitumor CTL from Patients with Multiple Myeloma Directed against HM1.24. Clinical Cancer Research. 11(9). 3377–3384. 25 indexed citations
17.
Kimura, Naoki, Shigeto Kawai, Yasuko Kinoshita, et al.. (2004). 2D7 diabody bound to the α2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells. Biochemical and Biophysical Research Communications. 325(4). 1201–1209. 8 indexed citations
18.
Kawai, Shigeto, Takao Kataoka, Hikaru Sugimoto, et al.. (2000). Santonin-related compound 2 inhibits the expression of ICAM-1 in response to IL-1 stimulation by blocking the signaling pathway upstream of IκB degradation. Immunopharmacology. 48(2). 129–135. 30 indexed citations
19.
Ohtomo, Toshihiko, Yasuhiro Sugamata, Koichiro Ono, et al.. (1999). Molecular Cloning and Characterization of a Surface Antigen Preferentially Overexpressed on Multiple Myeloma Cells. Biochemical and Biophysical Research Communications. 258(3). 583–591. 174 indexed citations
20.
Ono, Koichiro, Toshihiko Ohtomo, Kenji Yoshida, et al.. (1999). The humanized anti-HM1.24 antibody effectively kills multiple myeloma cells by human effector cell-mediated cytotoxicity. Molecular Immunology. 36(6). 387–395. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnaud Dupuy d’Angeac Breakdown of academic impact, for papers by Barbara J. Vilen Breakdown of academic impact, for papers by Keisuke Horikawa Breakdown of academic impact, for papers by Gabriele Beck‐Engeser Breakdown of academic impact, for papers by Erica N Evans Breakdown of academic impact, for papers by A. Miyajima Breakdown of academic impact, for papers by Boris Brill Breakdown of academic impact, for papers by Meina Tang Breakdown of academic impact, for papers by R. E. Schmidt Breakdown of academic impact, for papers by John Marken
Rankless by CCL
2026